Target-controlled Versus Manually-controlled Propofol Sedation in Flexible Bronchoscopy. A Randomized Non-inferiority Trial.
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Lung Cancer
- Sponsor
- Daniel Franzen
- Enrollment
- 78
- Locations
- 1
- Primary Endpoint
- Mean arterial oxygen saturation
- Status
- Completed
- Last Updated
- 10 years ago
Overview
Brief Summary
After randomization, the subjects undergo flexible bronchoscopy either with fractionated propofol administration or with propofol-TCI. Measurement of blood pressure, heart rate, oxygen saturation, and oxygen requirement are measured continuously during the procedure and thereafter. Cumulative propofol dose, and induction, procedure, and recovery time are noted continuously during and after the procedure.
Detailed Description
In daily clinical praxis, propofol sedation is given manually in repeated doses (fractionated) by a specially-trained nurse in attendance of the bronchoscopist. But, fractionated propofol administration (FPA) may lead to oversedation and enhanced side effects (oxygen desaturation and arterial hypotension), as a stable plasma concentration of propofol is not maintainable. In contrast to FPA, continuous infusions of propofol are commonly used to induce and maintain long-term sedation in intensive care units and general anesthesia. Recently, continuous propofol infusion for sedation in bronchoscopy has been shown comparable to FPA in terms of safety and efficacy. Generally, infusion devices can be manually controlled (MCI) or target-controlled (TCI). In the latter, the physician sets a target blood concentration and the computerized infusion device makes the necessary changes to the infusion rate. The objective of this study is to compare propofol TCI with FPA in flexible bronchoscopy concerning patient safety and sedation quality.
Investigators
Daniel Franzen
Dr. Daniel Franzen
University of Zurich
Eligibility Criteria
Inclusion Criteria
- •Subjects undergoing a planned, ambulatory flexible bronchoscopy (for transbronchial lung biopsy or endobronchial ultrasound guided procedures) in moderate sedation, aged between 18 and 85 years
Exclusion Criteria
- •History of solid organ or bone marrow transplantation with the use of an immunosuppressive therapy
- •HIV infection on anti-retroviral therapy
- •Alcohol consumption more than two standard drinks per day
- •Use of illicit drugs (heroin, opiates)
- •Any contraindication to use propofol for sedation (e.g. allergy)
- •Body mass index \> 35 kg/m2
- •Mental disorder preventing appropriate judgment concerning study participation
- •Missing written patient's informed consent
Outcomes
Primary Outcomes
Mean arterial oxygen saturation
Time Frame: During bronchoscopy
From induction of sedation until recovery (eye opening/answer to verbal stimuli), in average 45 minutes
Secondary Outcomes
- Number of occasions with a systolic blood pressure < 90 mmHg during bronchoscopy, maximum oxygen requirement,(During bronchoscopy)
- Number of occasions with recorded an oxygen saturation of < 90%(During bronchoscopy)
- Number of an oxygen desaturation of > 4% from baseline(During bronchoscopy)
- Frequency of dose adjustments(During bronchoscopy)
- Cumulative propofol dose(At end of bronchoscopy)
- Recovery time after bronchoscopy(During 2 hours after bronchoscopy)